Georgia policymakers, county officials and the NAACP are asking the federal government to investigate Wellstar Health System’s closure of two Atlanta-area hospitals in predominantly Black neighborhoods.
The latest request came from the Fulton County Commission…
FDA approval of Pfizer nasal spray migraine drug Zavzpret last week means a $475 million payday for Royalty Pharma. The payment stems from a financing deal Pfizer inherited when it acquired rights to the…
Continue Reading
The Food and Drug Administration’s Dr. Robert Califf called on insurers Thursday to help ensure that studies on new drugs in the accelerated approval pathway are still completed.
“I don’t think it’s just a matter…
At the MedCity INVEST conference at the Ritz Carlton in Chicago May 22-24, a panel will focus on violence against healthcare professionals. It’s an unfortunate trend that is on the rise, spurred by misinformation…
Continue Reading
New medications take too long to get into the hands of people who need them – a decade, on average. The leading cause of delays is finding patients for clinical trials, but it shouldn’t…
Continue Reading
Vaccine developer Vaxart contends its pill vaccinations against Covid-19 will be preferable to patients, and potentially more effective than currently available injections. But a different virus offers the biotech a clearer and faster path…
Continue Reading
By Mark Melchionna
March 16, 2023 – With support from Outbound AI, the Health Management Academy (the Academy) conducted a survey showing that due to common staffing issues within health systems, many C-suite executives…
By Hannah Nelson
March 16, 2023 – Medication administration technology (MAT) system inefficiencies complicate nurses’ EHR workflows, according to a study published in JAMIA.
Researchers conducted interviews with 32 nurses practicing at two urban health…
SpectrumAi, a startup focused on autism care, announced it raised up to $20 million in a Series A funding round led by CVS Health Ventures with participation from Cobalt Ventures.Previous investors Frist Cressey, F-Prime…
Continue Reading
